View Older Stories

Jul 16, 2025 11:17AM Form SCHEDULE 13G Semler Scientific, Inc. Filed by: Ridgeback Capital Investments L.P.

Jun 4, 2025 04:01PM Form SCHEDULE 13G iTeos Therapeutics, Inc. Filed by: Ridgeback Capital Investments L.P.

May 20, 2025 04:01PM Form SCHEDULE 13G/A Affimed N.V. Filed by: Ridgeback Capital Investments L.P.

Feb 14, 2025 04:02PM Form SCHEDULE 13G/A Pyxis Oncology, Inc. Filed by: Ridgeback Capital Investments L.P.

Jul 29, 2024 04:13PM Form SC 13G LENZ Therapeutics, Inc. Filed by: Ridgeback Capital Investments L.P.

Mar 25, 2024 06:30AM Nkarta (NKTX) Prices $240M Share and Warrant Offering at $10/sh

Mar 25, 2024 06:30AM Nkarta Announces Pricing of $240 Million Underwritten Offering

Mar 21, 2024 07:30AM Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023

Feb 27, 2024 08:08AM Pyxis Oncology (PYXS) Announces $50 Million Private Placement

Feb 27, 2024 08:00AM Pyxis Oncology Announces $50 Million Private Placement

Feb 14, 2024 04:11PM Form SC 13G/A BICYCLE THERAPEUTICS Filed by: Ridgeback Capital Investments L.P.

Feb 14, 2024 04:09PM Form SC 13G/A Affimed N.V. Filed by: Ridgeback Capital Investments L.P.

Jan 26, 2024 04:36PM Form SC 13G Pyxis Oncology, Inc. Filed by: Ridgeback Capital Investments L.P.

Feb 14, 2023 04:19PM Form SC 13G/A Affimed N.V. Filed by: Ridgeback Capital Investments L.P.

Feb 14, 2023 04:12PM Form SC 13G/A F-star Therapeutics, Filed by: Ridgeback Capital Investments L.P.

Feb 14, 2023 04:10PM Form SC 13G/A BICYCLE THERAPEUTICS Filed by: Ridgeback Capital Investments L.P.

Feb 14, 2023 04:04PM Form SC 13G/A F-star Therapeutics, Filed by: Ridgeback Capital Investments L.P.

Feb 14, 2023 04:04PM Form SC 13G/A Affimed N.V. Filed by: Ridgeback Capital Investments L.P.

Feb 14, 2023 04:01PM Form SC 13G/A BICYCLE THERAPEUTICS Filed by: Ridgeback Capital Investments L.P.

Feb 14, 2022 04:46PM Form SC 13G/A Affimed N.V. Filed by: Ridgeback Capital Investments L.P.

Feb 14, 2022 04:23PM Form SC 13G/A F-star Therapeutics, Filed by: Ridgeback Capital Investments L.P.

Feb 14, 2022 04:22PM Form SC 13G/A BICYCLE THERAPEUTICS Filed by: Ridgeback Capital Investments L.P.

Feb 14, 2022 04:22PM Form SC 13G/A Cogent Biosciences, Inc. Filed by: Ridgeback Capital Investments L.P.

Jan 6, 2022 09:00AM Garuda Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference

Dec 2, 2021 08:00AM Acepodia Raises $109 Million Series C Financing to Advance Development of First-in-Class Antibody Cell Effector Therapies

Nov 29, 2021 12:05AM Jeito Capital co-leads $156 million oversubscribed Series B financing in Quell Therapeutics

Nov 29, 2021 12:05AM Jeito Capital co-leads $156 million oversubscribed Series B financing in Quell Therapeutics

Nov 29, 2021 12:00AM Quell Therapeutics Raises $156 million in Oversubscribed Series B Financing to Advance its Pioneering Multi-Modular Engineered T Regulatory (Treg) Cell Therapy Pipeline and Platform

Nov 9, 2021 07:00AM Arbor Biotechnologies Closes $215 Million Oversubscribed Series B Financing to Advance Next-Generation Precision Editing Therapeutics

Sep 23, 2021 08:00AM Garuda Therapeutics Launches with $72 Million Series A Financing

Jul 21, 2021 06:00AM Turnstone Biologics Raises $80 Million Series D Financing

Apr 14, 2021 11:26AM Form SC 13G Affimed N.V. Filed by: Ridgeback Capital Investments L.P.

Apr 9, 2021 04:54PM Form SC 13G/A F-star Therapeutics, Filed by: Ridgeback Capital Investments L.P.

Mar 30, 2021 08:00AM Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics

Mar 16, 2021 08:00AM Acepodia Completes $47 Million Series B Financing to Advance Pipeline of Allogeneic Cell Therapy Candidates

Mar 3, 2021 08:00AM Caribou Biosciences Raises $115M Series C Financing to Advance Next-Generation CRISPR Technologies and Allogeneic Cell Therapy Pipeline

Feb 16, 2021 04:34PM Form SC 13G/A Verastem, Inc. Filed by: Ridgeback Capital Investments L.P.

Feb 16, 2021 04:34PM Form SC 13G/A MYOMO, INC. Filed by: Ridgeback Capital Investments L.P.

Feb 16, 2021 04:30PM Form SC 13G/A SUTRO BIOPHARMA, INC. Filed by: Ridgeback Capital Investments L.P.

Feb 16, 2021 04:30PM Form SC 13G/A F-star Therapeutics, Filed by: Ridgeback Capital Investments L.P.

Feb 16, 2021 04:26PM Form SC 13G/A 4D Molecular Therapeutic Filed by: Ridgeback Capital Investments L.P.

Feb 16, 2021 04:26PM Form SC 13G/A Cogent Biosciences, Inc. Filed by: Ridgeback Capital Investments L.P.

Feb 16, 2021 04:23PM Form SC 13G/A BICYCLE THERAPEUTICS Filed by: Ridgeback Capital Investments L.P.

Dec 23, 2020 04:02PM Form SC 13G 4D Molecular Therapeutic Filed by: Ridgeback Capital Investments L.P.

Aug 25, 2020 06:02AM Form SC 13G SUTRO BIOPHARMA, INC. Filed by: Ridgeback Capital Investments L.P.

Jul 16, 2020 04:13PM Form SC 13G Unum Therapeutics Inc. Filed by: Ridgeback Capital Investments L.P.

Jul 13, 2020 04:29PM Form SC 13G BICYCLE THERAPEUTICS Filed by: Ridgeback Capital Investments L.P.

Jun 16, 2020 07:00AM 4D Molecular Therapeutics Raises $75 Million in Series C Financing

Mar 6, 2020 04:29PM Form 4 Verastem, Inc. For: Mar 06 Filed by: Ridgeback Capital Investments Ltd.

Mar 6, 2020 04:03PM Form SC 13G/A Verastem, Inc. Filed by: Ridgeback Capital Investments L.P.

View Older Stories